Colton D M, Till G O, Johnson K J, Dean S B, Bartlett R H, Hirschl R B
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0245, USA.
Crit Care Med. 1998 Oct;26(10):1716-24. doi: 10.1097/00003246-199810000-00028.
This study evaluates the ability of perflubron to inhibit pulmonary neutrophil accumulation during partial liquid ventilation (PLV) in the setting of acute lung injury.
Randomized, controlled, nonblinded study.
Research laboratory at a university.
Male, Sprague-Dawley rats (n = 120, 506 +/- 42 g).
Animals were divided into eight groups (n = 15 in each group, of which n = 12 for myeloperoxidase content and n = 3 for histologic neutrophil counting): a) GV-CVF group, animals received gas ventilation (GV) with the induction of lung injury using cobra venom factor (CVF); b) PLV-CVF group, animals received partial liquid ventilation before the induction of lung injury; c) PEEP-CVF group, animals received positive end-expiratory pressure (PEEP) before the administration of cobra venom factor; d) CVF-PLV group, animals received partial liquid ventilation after cobra venom factor; e) CVF-PEEP group, animals received PEEP after cobra venom factor; f) PLV only group, animals received partial liquid ventilation only; g) GV only group, animals received gas ventilation only; and h) NVSBA group, nonventilated spontaneous breathing animals.
After the experimental period, total lung myeloperoxidase content was significantly decreased in the PLV-CVF (0.29 +/- 0.08, p = .02) and PEEP-CVF (0.34 +/- 0.04, p = .01) groups when compared with the GV-CVF group (0.62 +/- 0.07). When compared with the GV-CVF group, a trend toward a reduction in myeloperoxidase was observed in the CVF-PLV (0.42 +/- 0.05, p = .07) and the CVF-PEEP (0.39 +/- 0.06, p = .07) groups. When compared with the cobra venom factor only group (GV-CVF 47 +/- 2 neutrophils/high-power field), reductions in neutrophil count were observed in all groups (neutrophils/high-power field): PLV-CVF (20 +/- 2, p = .009); PEEP-CVF (24 +/- 1, p = .01); CVF-PLV (30 +/- 2, p = .03); and CVF-PEEP (37 +/- 1, p = .04).
These data suggest that both partial liquid ventilation and PEEP result in a reduction in neutrophil accumulation in the setting of acute lung injury.
本研究评估全氟溴辛烷在急性肺损伤情况下部分液体通气(PLV)期间抑制肺中性粒细胞积聚的能力。
随机、对照、非盲研究。
一所大学的研究实验室。
雄性Sprague-Dawley大鼠(n = 120,体重506±42 g)。
动物分为八组(每组n = 15,其中n = 12用于测定髓过氧化物酶含量,n = 3用于组织学中性粒细胞计数):a)气体通气-眼镜蛇毒因子(GV-CVF)组,动物接受气体通气(GV)并使用眼镜蛇毒因子(CVF)诱导肺损伤;b)部分液体通气-眼镜蛇毒因子(PLV-CVF)组,动物在诱导肺损伤前接受部分液体通气;c)呼气末正压-眼镜蛇毒因子(PEEP-CVF)组,动物在给予眼镜蛇毒因子前接受呼气末正压(PEEP);d)眼镜蛇毒因子-部分液体通气(CVF-PLV)组,动物在眼镜蛇毒因子处理后接受部分液体通气;e)眼镜蛇毒因子-呼气末正压(CVF-PEEP)组,动物在眼镜蛇毒因子处理后接受PEEP;f)仅部分液体通气(PLV only)组,动物仅接受部分液体通气;g)仅气体通气(GV only)组,动物仅接受气体通气;h)非通气自主呼吸动物(NVSBA)组。
实验期结束后,与气体通气-眼镜蛇毒因子(GV-CVF)组(0.62±0.07)相比,部分液体通气-眼镜蛇毒因子(PLV-CVF)组(0.29±0.08,p = 0.02)和呼气末正压-眼镜蛇毒因子(PEEP-CVF)组(0.34±0.04,p = 0.01)总肺髓过氧化物酶含量显著降低。与气体通气-眼镜蛇毒因子(GV-CVF)组相比,眼镜蛇毒因子-部分液体通气(CVF-PLV)组(0.42±0.05,p = 0.07)和眼镜蛇毒因子-呼气末正压(CVF-PEEP)组(0.39±0.06,p = 0.07)观察到髓过氧化物酶有降低趋势。与仅眼镜蛇毒因子组(GV-CVF组47±2个中性粒细胞/高倍视野)相比,所有组中性粒细胞计数均降低(中性粒细胞/高倍视野):部分液体通气-眼镜蛇毒因子(PLV-CVF)组(20±2,p = 0.009);呼气末正压-眼镜蛇毒因子(PEEP-CVF)组(24±1,p = 0.01);眼镜蛇毒因子-部分液体通气(CVF-PLV)组(30±2,p = 0.03);眼镜蛇毒因子-呼气末正压(CVF-PEEP)组(37±1,p = 0.04)。
这些数据表明,在急性肺损伤情况下,部分液体通气和呼气末正压均可减少中性粒细胞积聚。